“Multivariate Genome-Wide Association Meta-Analysis of over 1 Million Subjects Identifies Loci Underlying Multiple Substance Use Disorders”, Alexander S. Hatoum, Sarah M. C. Colbert, Emma C. Johnson, Spencer B. Huggett, Joseph D. Deak, Gita A. Pathak, Mariela V. Jennings, Sarah E. Paul, Nicole R. Karcher, Isabella Hansen, David A. A. Baranger, Alexis Edwards, Andrew David Grotzinger, Substance Use Disorder Working Group of the Psychiatric Genomics Consortium, Elliot M. Tucker-Drob, Henry Kranzler, Lea K. Davis, Sandra Sanchez-Roige, Renato Polimanti, Joel Gelernter, Howard J. Edenberg, Ryan Bogdan, Arpana Agrawal2022-01-12 (, , ; similar)⁠:

Genetic liability to substance use disorders can be parsed into loci conferring general and substance-specific addiction risk. We report a multivariate genome-wide association study that disaggregates general and substance-specific loci for problematic alcohol use, problematic tobacco use, and cannabis and opioid use disorders in a sample of 1,025,550 individuals of European and 92,630 individuals of African descent.

Nineteen loci were genome-wide statistically-significant for the general addiction risk factor (addiction-rf), which showed high polygenicity. Across ancestries PDE4B was (among others), suggesting dopamine regulation as a cross-trait vulnerability. The addiction-rf polygenic risk score was associated with substance use disorders, psychopathologies, somatic conditions, and environments associated with the onset of addictions.

Substance-specific loci (9 for alcohol, 32 for tobacco, 5 for cannabis, 1 for opioids) included metabolic and receptor genes.

These findings provide insight into the genetic architecture of general and substance-specific use disorder risk that may be leveraged as treatment targets.